Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Improvement of ω-3 fatty acids-rich supplement on perioperative immune responses in patients undergoing cardiac surgery

2nd International Summit on Clinical Pharmacy

Kazuo Nakamura

ScientificTracks Abstracts: Clinic Pharmacol Biopharm

DOI: 10.4172/2167-065X.S1.006

Abstract
We conducted a pilot study in patients undergoing cardiac surgery to investigate the influence of a dietary supplement enriched in omega-3 fatty acids on immune responses. Patients in the supplement group (n=7) received a dietary supplement enriched in ω-3 fatty acids, namely Impact� for 5 successive days before surgery; those in the control group (n=7) did not receive Impact�. Blood samples in both groups were collected at same time points. Before surgery, samples were collected on 5 days before surgery at the start of supplementation (baseline) and the end of supplementation (postoperative day (POD)-0). After surgery, samples were collected on POD-1 and POD-7. The expression of human leukocyte antigen (HLA)-DR, the ratio of CD4-/CD8-positive cells, the production of IFN-γ by CD4-positive cells, plasma levels of cytokines, and leukocyte-platelet aggregates were measured. Before surgery (POD-0), the supplement caused significant increases in HLA-DR expression, CD4/ CD8 ratio, and plasma levels of IFN-γ; these levels were significantly higher compared to those in the control group (p<0.01, respectively). After surgery (POD-1), all values dramatically decreased in comparison with those of POD-0; however, the values in the supplement group were significantly higher compared to their respective markers in the control group (p<0.05, respectively). Significant differences of HLA-DR expression and CD4/CD8 ratio persisted through POD-7. Before surgery (POD-0), plasma levels of IL-10 in the supplement group decreased significantly compared with those in the control group (p<0.05). After surgery (POD-1), plasma levels of IL-10 in both the control and supplement groups increased; these levels in the supplement group were significantly lower than those in the control group (p<0.01). Significant decreases in the percentage of leukocyte-platelet aggregates were found after supplementation; the difference between the supplement and the control groups was found on POD-0 and POD-1 (P<0.01, respectively). In conclusion, the dietary supplement increased HLA-DR expression, the CD4/CD8 ratio, and the production of IFN-γ by CD4-positive cells; conversely, the levels of IL-10 and the formation of leukocyte-platelet aggregates before and after surgery were suppressed. These beneficial effects may decrease the incidence of complications after surgery.
Biography
Top